Companies across the globe are putting their planned initial public offerings on ice as the spread of the coronavirus rocks equity markets and dampens investor appetite for new investments.

Carlyle Group has already delayed the US IPO of German specialty chemicals manufacturer Atotech over concerns that the virus could negatively impact the valuation it would achieve with investors, according to a report by Reuters.